Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-01-24 @ 4:04 PM
Study NCT ID:
NCT04898634
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2021-05-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
Sponsor:
Janssen Research & Development, LLC
Organization: